Purchase Order 75N93020P01090

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for sequencing kits valued at $19,072.05, with an award date of April 13, 2021 and completion date of May 12, 2021. Performance occurs in San Diego, California. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a $9,947.04 delivery order to Illumina, Inc. on August 30, 2017, for a sequencing kit.</p> <p>Place of performance is San Diego, CA 92122. The order has a firm fixed-price structure and an ultimate completion date of September 7, 2017.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Illumina, Inc. on September 4, 2019, for Illumina reagents and consumables with a ceiling value of $14,830.29.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a $14,535.00 delivery order to Illumina, Inc. on December 9, 2019, for ISEQ 100 I1 Reagent 4 Pack (Quantity 6).</p> <p>Place of performance is San Diego, CA 92122. The order was firm fixed price with an ultimate completion date of December 8, 2020. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a $4,962.26 delivery order to Illumina, Inc., on August 30, 2017, for Illumina sequencing kits.</p> <p>Place of performance is San Diego, CA 92122. The order has a firm fixed-price structure with an ultimate completion date of September 8, 2017. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a $4,419.86 delivery order to Illumina, Inc. on August 30, 2017, for sequencing kits.</p> <p>Place of performance is San Diego, CA 92122. The order has a firm fixed-price structure with an ultimate completion date of September 8, 2017. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc., valued at $13,724.10, for a MiSeq Reagent Kit V3 (600-cycle) on September 2, 2020. Place of performance is Bethesda, Maryland. The order was firm fixed-price with an ultimate completion date of October 3, 2020 and was funded under the Coronavirus COVID-19 National Interest Action Code.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for $14,688.00 on August 14, 2020, for NovaSeq 6000 S4 reagent kits (300 cycles) in support of COVID-19 research. Place of performance is San Diego, California. The order carries firm fixed-price pricing with an ultimate completion date of September 4, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Illumina, Inc. on August 21, 2018, with a ceiling value of $148,811.70 for Illumina consumables.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of August 27, 2019 and is priced on a firm fixed-price basis. No set-aside was used for this delivery order.</p>

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $45,601.92 delivery order contract to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide consumable reagents in support of the agency's research efforts. The delivery order was issued against an existing Indefinite Delivery Indefinite Quantity contract vehicle and extends from July 11, 2023 through September 30, 2023. Performance will take place in...